Discussion  by unknown
CONCLUSION
CAS is as technically feasible, safe, and durable in
anatomically high-risk patients as in medically high-risk
patients, with similar rates of periprocedural stroke, death,
and late restenosis. However, patients with radiation-
induced stenosis appear to be at an increased risk for res-
tenosis.
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DISCUSSION
Dr Peter Lin (Houston, Tex). Dr Shin and her colleagues from
the Eastern Virginia Medical School should be congratulated for
an excellent clinical study in which they analyzed the clinical
outcome of carotid stenting in patients who have high-risk medical
comorbidities vs those with anatomically high-risk lesions. The
authors reported similar clinical outcome in terms of stroke and
mortality between the two groups. However, patients with
radiation-induced stenosis had a much higher risk of restenosis
compared to the medically high-risk cohorts. I have three ques-
tions for the author.
My first question relates to the ultrasound surveillance. The
higher risks of restenosis in patients with radiation-induced carotid
lesions, inmy view, warrants a more vigilant or frequent ultrasound
surveillance protocol since the need for reintervention is undoubt-
edly higher. Can you share with us your view whether a more
vigilant surveillance protocol is necessary in this particular patient
cohort? If so, what should be the ideal surveillance protocol in
these patients?
Second, in your study, a variety of carotid stents including the
Smart, Precise, and Acculink stents were used. There have been
studies in the recent literature to suggest these nitinol stents, which
are considered a open-cell stent, have lower patency compared to
closed-cell stents such as Wallstent. This is a finding that we have
also validated in our own clinical experience. This finding has also
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led some researchers to advocate the notion that different carotid
stent should be applied based on patients’ anatomical factors. Can
you share with us with your opinion regarding the notion that
different devices (ie, open- vs closed-cell stent) should be applied
to different patient cohorts based on the higher risk of restenosis?
My last question has to do with the ultrasound criteria which
you based to determine the degree of restenosis. In our practice,
we have found the velocity criteria used to determine carotid
stenting-related restenosis varies based on the stent used. In other
words, we have noted that the same velocity criteria used for a
nitinol stent does not apply to the Wallstent. We also learned that
same velocity criteria for de novo carotid lesion do not apply to
lesion of carotid stent-related restenosis. How did you derive your
velocity criteria in your study? Have your found a difference in
velocity criteria based on the stents used in your study?
I’d like to thank the authors for providing me with a well-
written manuscript well ahead of time. I’d also want to thank the
association for the opportunity to discuss this paper.
Dr Susanna H. Shin. Thank you for your comments and
your questions. Your first question is on the surveillance of our
patients. Routinely, our patients undergo a duplex ultrasound
within 24 hours of their procedure, then at 1 month and 6
months, and annually thereafter. In our study, we had patients
in the radiation cohort who developed restenosis at 7.5 months,
9.1 months, 13 months, and at 58 months. Currently, we do
not have a different protocol for following up these patients
more often, perhaps that would lead us to detecting restenoses
earlier and potentially provide for them to have reintervention
sooner.
Your second question was based on the type of stent. The
majority of our patients were part of a trial. Obviously, the stent
choice was predetermined, and therefore dictated by that trial and
the majority of our patients received open-cell stents. Future
directions would be potentially to use closed-cell stents, which
might be better in this specific cohort of radiation-induced steno-
sis, and perhaps another option would be using drug-eluting stents
or covered stents.
For stenosis criteria, we don’t use, at this time, different
velocity criteria for different stents. We currently use the estab-
lished criteria set forth by Dr AbuRhama and currently we are
looking at our own duplex velocity data and comparing them to
our angiograms to see how they correlate and potentially come up
with new criteria for those stents.
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